Circulating cytokines and complements in chronic heart failure

Area of Science:

• Cardiology
• Immunology
• Biochemistry

Background:

• Cytokines and complements are elevated in advanced heart failure.
• Their precise clinical significance and role in chronic heart failure pathogenesis are unclear.
• Hemodynamic and clinical variable correlations may elucidate their actions.

Purpose of the Study:

• To evaluate the clinical significance of cytokines and complements in chronic heart failure.
• To assess the relationship between these markers and patient outcomes.

Main Methods:

• Study included 60 patients with chronic heart failure (34 idiopathic dilated cardiomyopathy, 26 ischemic heart disease) and controls.
• Measured concentrations of Tumor Necrosis Factor alpha and Interleukin-2 receptor.
• Correlated marker levels with clinical variables and mortality.

Main Results:

• Elevated Tumor Necrosis Factor alpha and Interleukin-2 receptor levels were observed in heart failure patients compared to controls.
• No significant differences in cytokine and complement levels were found between dilated cardiomyopathy and ischemic heart disease patients.
• Higher functional class patients showed a non-significant trend towards increased cytokine and complement levels.
• Circulating cytokine and complement levels independently predicted mortality.

Conclusions:

• Humoral and cellular immunity abnormalities may contribute to the pathogenesis of heart failure and dilated cardiomyopathy.
• Elevated cytokines and complements are significant indicators of mortality risk in heart failure patients.